How GLP-1s Work (and What They Don’t Do)

For many people, one of the strangest things about starting a GLP-1 medication is how ordinary food suddenly feels.

You get full sooner.

A portion that once seemed normal feels like too much.

You may go several hours without thinking about food at all.

That shift can be powerful, especially for someone who has spent years feeling as though weight management required a constant negotiation with hunger.

But it can also create a new problem.

When eating becomes easier to do less of, eating well becomes more important.

GLP-1-based medications can help regulate appetite and reduce calorie intake. They do not provide protein. They do not build muscle. They do not hydrate you. They do not replace sleep, strength training or adequate nutrition.

Understanding that distinction is one of the most important parts of using them well.

GLP-1 is a hormone involved in appetite and glucose regulation.

Medications such as semaglutide activate the GLP-1 receptor. Tirzepatide is slightly different: it activates both GIP and GLP-1 receptors. Both influence pathways involved in appetite and food intake. They also affect insulin and glucagon in a glucose-dependent manner and delay gastric emptying. [1,2]

The practical result is often straightforward:

You feel satisfied with less food.

FDA prescribing information for both semaglutide and tirzepatide specifically notes that they reduce calorie intake, with effects likely mediated through appetite. [1,2]

That is different from simply “speeding up your metabolism.”

And it is different from a medication somehow melting fat independent of what you eat.

The medication changes an important part of the equation: how much food your brain and body are asking you to consume.

What happens inside that smaller amount of food still matters.

This is where the conversation can get distorted.

If eating less produces weight loss, it can be tempting to assume that eating even less must produce a better result.

Not necessarily.

The FDA-approved weight-management uses of semaglutide and tirzepatide are intended alongside a reduced-calorie diet and physical activity, not nutritional deprivation. [1,2]

A 2025 joint advisory from four major nutrition and obesity organizations went further. It emphasized that people taking GLP-1-based therapies may need additional attention to nutrient quality because substantial reductions in appetite can make it more difficult to consume adequate protein, vitamins, minerals and total nutrition. [3]

This changes the priority.

Before treatment, someone may have been trying to control quantity.

During treatment, the more useful question may become:

What deserves space on my plate when I don't want very much food?

Weight loss does not exclusively come from body fat.

Some lean tissue is typically lost during meaningful weight reduction, regardless of the method used to lose weight. In a body-composition substudy of the SURMOUNT-1 tirzepatide trial, approximately 75% of the weight lost was fat mass and 25% was lean mass. [4]

That does not mean 25% of everyone's weight loss will be muscle. Lean mass includes more than skeletal muscle, and individual results vary.

But it illustrates why the scale cannot be the only objective.

Research across weight-loss interventions suggests that higher protein intake can help protect lean mass during an energy deficit, particularly when combined with resistance exercise. [3,5]

When appetite is limited, protein therefore deserves priority.

Think eggs or Greek yogurt in the morning. Fish, chicken, tofu, cottage cheese, beans, lentils or another protein source later in the day. If a large meal feels unappealing, smaller protein-containing meals or a thoughtfully built smoothie may be more manageable.

And if you're unsure what an appropriate protein target looks like for your size, activity and goal, the ANUWELL Protein Calculator can give you a practical starting range rather than a generic number.

One important caveat: protein is not a substitute for strength training.

Protein supplies the building blocks. Resistance training gives the muscle a reason to keep them. The 2025 GLP-1 nutrition advisory specifically recommends combining appropriate protein intake with structured strength training to support muscle preservation. [3]

When weight loss is the goal, carbohydrates are often the first thing people try to eliminate.

That can become especially easy on a GLP-1 because appetite is already low.

But there is a meaningful difference between reducing refined carbohydrates and eliminating useful sources of carbohydrate altogether.

The joint clinical advisory on GLP-1 nutrition recommends nutrient-dense foods including fruit, vegetables, whole grains and legumes, while minimizing refined grains, added sugars and sugar-sweetened beverages. [3]

That can look like oats.

Fruit.

Beans or lentils.

Quinoa or brown rice.

Potatoes or sweet potatoes.

Whole-grain bread.

Vegetables.

In other words, the goal is not no carbohydrates.

It is better carbohydrates, in an amount that fits your energy needs and goals.

This matters particularly if you are exercising. If your portions have become very small and you've simultaneously stripped out most sources of carbohydrate, protein and total calories, feeling depleted should not automatically be interpreted as proof that the medication is “working.”

Fatigue is also reported as a common adverse reaction with semaglutide, and low blood sugar can occur under certain circumstances, particularly when GLP-1 therapy is combined with some diabetes medications. Persistent or significant fatigue, weakness, dizziness or other concerning symptoms should be discussed with your clinician rather than managed by simply restricting food further. [1]

GLP-1 medications can make a calorie deficit happen almost accidentally.

That does not mean the biggest possible deficit is desirable.

Eating dramatically below your body's needs can make it harder to consume adequate protein and micronutrients, maintain activity and support lean mass. The current expert advisory recommends individualizing both calorie restriction and treatment based on the patient's health, goals and response. [3]

ANUWELL's Calorie Deficit Calculator is useful here because it estimates maintenance needs and a potential weight-loss target based on factors including body size, age and activity.

The philosophy behind it is worth remembering:

The important word is deficit, not deprivation.

A calculator cannot prescribe what you personally should eat, particularly if you have medical conditions or are taking medication. But it can help put your intake into context.

Food contributes fluid.

So when people suddenly eat significantly less, one source of daily fluid quietly shrinks too.

Add nausea, vomiting or diarrhea, all recognized gastrointestinal side effects of GLP-1-based medications, and dehydration can become more important than people expect. FDA prescribing information specifically warns that gastrointestinal fluid losses can lead to dehydration and, in some cases, kidney injury. [1,2]

So hydration should be intentional.

Drink consistently rather than waiting until you feel noticeably thirsty. Pay closer attention during hot weather, travel, exercise or periods of gastrointestinal symptoms.

And persistent vomiting, diarrhea or difficulty keeping fluids down deserves a call to your healthcare provider.

A smaller appetite should not become a smaller hydration habit.

A medication that reduces appetite does not make sleep irrelevant.

In one randomized clinical trial involving adults with overweight who habitually slept fewer than 6.5 hours per night, a sleep-extension intervention increased sleep by about 1.2 hours and was associated with an average reduction in energy intake of approximately 270 calories per day compared with the control group. [6]

That does not mean sleeping more produces a predictable amount of weight loss, and the study population was relatively young.

It does reinforce something larger:

Weight regulation does not happen in isolation from the rest of your biology.

Sleep affects how you feel, how you recover, whether you want to exercise and how sustainable your routine feels. The 2025 GLP-1 advisory includes sleep alongside nutrition, strength, physical activity and stress as part of comprehensive care during treatment. [3]

So if the medication is working beautifully but you're sleeping five hours a night, that is not a reason to ignore the five hours.

This may be one of the most important distinctions.

A lower number on the scale is not automatically synonymous with a better body composition.

As weight falls, preserving strength and lean mass becomes part of the job.

That means:

Adequate protein. Strength training. Enough total nutrition. Appropriate recovery.

The goal is not simply to become lighter.

It is to come out of weight loss metabolically healthier, physically capable and able to maintain the activities that matter to you.

That becomes increasingly important in midlife and beyond, when maintaining muscle has implications far beyond appearance.

Another misconception is that a GLP-1 simply teaches the body to eat less and, eventually, the medication is no longer needed.

That is not what clinical withdrawal studies have shown.

In an extension of the STEP 1 trial, participants who discontinued semaglutide regained, on average, about two-thirds of their prior weight loss during the following year. [7]

In the SURMOUNT-4 trial, people who discontinued tirzepatide after an initial treatment period experienced substantial weight regain, while those who continued treatment maintained and added to their initial weight reduction. [8]

That does not tell us what every individual should do, or that treatment duration should be identical for everyone.

It tells us something more useful:

Weight regulation is biological.

Medication can influence that biology while you are taking it. Nutrition, movement, muscle, sleep and sustainable habits remain important because medication is one part of the system, not the entire system.

Any decision to continue, change or discontinue treatment should be made with the prescribing clinician.

They do not decide whether the food you eat contains enough protein.

They do not know whether your calorie deficit has become too aggressive.

They do not lift weights for you.

They do not replenish the fluid you lost after a day of nausea.

They do not turn five hours of sleep into eight.

And they do not tell you whether the weight you are losing is producing the health outcome you actually wanted.

That is where thoughtful care comes in.

Not simply asking:

“Is the scale moving?”

But also:

Are you eating enough protein?

Are you still able to train?

Do you have energy?

Are you hydrated?

Are you sleeping?

How are your labs changing?

How do you feel?

Is the treatment still appropriate for you?

GLP-1s have changed what is possible in medical weight management.

For many people, they can remove a level of hunger that previously made meaningful weight loss extraordinarily difficult.

That matters.

But appetite suppression is the tool, not the destination.

The objective is to use the opportunity it creates to build something better underneath it.

Better nutrition.

More muscle.

Better metabolic health.

Better sleep.

More energy.

A way of eating that supports the body you're trying to create rather than simply producing the smallest number possible.

The goal isn't to eat as little as you can.

It's to make what you do eat count.